valtrim tablets x 100's
sulphamethoxazole 400mg trimethoprim 80mg
vericom co. ltd denfil™ etchant
nxgenz pte. ltd. - dental - denfiltm etchant-37 is phosphoric acid formulation thickened with natural polymeric materials. denfiltm etchant-37 contains 37% phosphoric acid and is designed as a semi-gel type. denfiltm etchant-37 can be obtained easy and available etching effect. also denfiltm etchant-37 leaves no residues on the surface of etched tooth contrary to silica thickened etchants.
vericom co. ltd v-etchtm
nxgenz pte. ltd. - dental - v-etchtm (35% phosphoric acid) is a viscous solution type that minimize to be blocked the tip by including a natural humectant. v-etchtm shows a rapid etching effect to enamel and dentin, and completely can be removed with smear layer upon rinsing. the thixotropic property of v-etchtm helps effective etching to the precise locations.
corvalol-mff
moscow pharmaceutical factory jsc - alfa-bromisovaleric acid ethyl ester, phenobarbital - drops oral - 20mg/ml+18,26mg/ml
corvalol farmak tablets
pjsc "farmak" - alfa-bromisovaleric acid ethyl ester, phenobarbital, peppermint oil - tablets - 12.42mg+ 11.34mg+ 0.88mg
corvalol-pharmstandard drops oral
pharmstandard-leksredstva jsc - alfa-bromisovaleric acid ethyl ester, phenobarbital, peppermint oil - drops oral - 20mg/ml+ 18,26mg/ml+ 1,42mg/ml
corvalol-pharmstandard drops oral
pharmstandard-leksredstva jsc - alfa-bromisovaleric acid ethyl ester, phenobarbital, peppermint oil - drops oral - 20mg/ml+ 18,26mg/ml+ 1,42mg/ml
corsiz tablets
aversi-rational ltd - alfa-bromisovaleric acid ethyl ester, phenobarbital, peppermint oil - tablets - 8,2mg+ 7,5mg+ 0,58mg
carbaglu
recordati rare diseases - carglumic acid - amino acid metabolism, inborn errors; propionic acidemia - other alimentary tract and metabolism products, - carbaglu is indicated in treatment of:hyperammonaemia due to n-acetylglutamate-synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.
ucedane
eurocept international bv - carglumic acid - hyperammonemia; amino acid metabolism, inborn errors - other alimentary tract and metabolism products, - ucedane is indicated in treatment of:hyperammonaemia due to n-acetylglutamate synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.